The global local anesthesia drugs market size is anticipated to reach USD 6.45 billion by 2025, according to a new report by Grand View Research, Inc., registering a 3.7% CAGR during the forecast period. The rising number of surgical procedures across the globe, including cosmetic surgeries, dental procedures, and plastic surgeries, is driving the growth of local anesthetics.
There
has been a considerable increase in the number of surgical procedures requiring
post-operative pain relief and this trend is expected to continue throughout
the forecast period. Roughly, 65.0% of total surgical procedures require
post-operative pain management. This is likely to boost the demand for local
anesthesia drugs.
The
introduction of new and effective drugs such as levobupivacaine, articaine, and
ropivacaine is also driving the growth of the local anesthesia drugs market
across the globe. Rising healthcare expenditure in developing countries is
expected to result in an increase in the number of surgeries performed in
countries such as India, China, and Brazil. This is likely to contribute to
market growth in the region.
Full Research Report On Local Anesthesia Drugs Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/local-anesthesia-drugs-market
Further key
findings from the study suggest:
- Lidocaine dominated the
market by product as of 2016 owing to its extensive use as a topical and
injectable anesthetic
- By application, the market
is bifurcated into injectable and surface anesthetic. The injectable
segment is expected to dominate the local anesthesia drugs market during
the forecast period owing to extensive usage in different surgical
procedures. Advancements in drug delivery systems are expected to drive
the market for surface anesthetics over the forecast period
- North America held the
largest share in the market for local anesthesia drugs owing to a
significant number of surgical procedures performed in the region
- Some of the key players are
Aspen Pharmacare; Fresenius Kabi; Novartis, Inc.; Sagent Pharmaceutical; Pacira
Pharmaceutical; Mylan; and Teva Pharmaceuticals.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/local-anesthesia-drugs-market/request/rs1
Grand View Research has segmented
the global local anesthesia drugs market on the basis of product, application,
and region:
Local Anesthesia
Drugs Product Outlook (Revenue, USD Million, 2014 - 2025)
- Bupivacaine
- Ropivacaine
- Lidocaine
- Chloroprocaine
- Prilocaine
- Benzocaine
- Other local anesthetics
Local Anesthesia
Drugs Application Outlook (Revenue, USD Million, 2014 - 2025)
- Injectable
- Surface Anesthetic
Local Anesthesia
Drugs Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- The U.S.
- Canada
- Europe
- Germany
- The U.K.
- Asia Pacific
- China
- Japan
- Latin America
- Brazil
- Mexico
- MEA
- South Africa
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment